Oil drillers cut rigs for third week in a row: Baker...
U.S. energy firms this week cut the number of oil rigs operating for a third week in a row to the lowest level in 10 months as independent producers follow through on plans to cut spending even though oil majors plan to spend more.
NSG Group Plans New U.S. Manufacturing Plant
NSG Group recently announced the location of its new glass production plant in the United States as part of the company’s plan to expand capacity and support the growing solar market. The 50…
U.S. oil drillers cut rigs for second week in a row...
U.S. energy firms cut oil rigs for a second week in a row as more producers, like Occidental Petroleum Corp, turned conservative in their 2019 drilling plans due to uncertainty over a recovery in crude prices.
Boston Scientific Announces Recommended Offer to Acquire BTG plc.
MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offe
Alibaba Upgrades Intellectual Property System With Blockchain
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs.
Drillers add oil rigs for second week in a row -Baker...
U.S. energy firms this week increased the number of oil rigs operating for a second week in a row amid concerns that crude supplies will swamp global demand as U.S. output keeps growing from record levels.
FDA Approves VAXELIS™, Sanofi and Merck’s Pediatric Hexavalent Combination Vaccine
Source: www.news.sanofi.us
The U.S. Food and Drug Administrator (FDA) has given its approval for Sanofi and Merck’s drug VAXELIS. This drug can be used as...
Aston Bay Completes Initial Drill Program at its Buckingham Gold Property...
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with...
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved both VYNDAQEL® (tafamidis meglumine) and VYNDAMAX
Nomura said to plan dozens of job cuts in Europe, America
Executives at the Tokyo-based firm may shed more than 100 traders and bankers across its overseas units.
